Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Zimmer

Showing results (71-80 of 87) with videos related to

Pageof 9
Sort By:
Journal of Translational Medicine|November 7, 2023
Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cureRafaëla Schober, Bianca Brandus, Thessa Laeremans, et al.
Frontiers in Immunology|August 16, 2021
Unbiased Screening Identifies Functional Differences in NK Cells After Early Life Psychosocial StressSara B Fernandes, Neha D Patil, Sophie Meriaux, et al.
Frontiers in Immunology|August 1, 2022
Imprint of Initial Education and Loss of Ly49C/I in Activated Natural Killer Cells of TAP1-KO and C57BL/6 Wildtype MiceNeha D Patil, Olivia Domingues, Cécile Masquelier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2014
NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I moleculesMarwan Sleiman, Nicolaas H C Brons, Tony Kaoma, et al.
Immunotargets and Therapy|September 12, 2025
Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast CancerCarole Seguin-Devaux, Bianca Brandus, Jean-Marc Plesseria, et al.
Plos One|October 1, 2014
Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastomaCecilie Brekke Rygh, Jian Wang, Marte Thuen, et al.
Frontiers in Immunology|July 5, 2017
Human CD56<sup>dim</sup>CD16<sup>dim</sup> Cells As an Individualized Natural Killer Cell SubsetMathieu Amand, Gilles Iserentant, Aurélie Poli, et al.
Oncotarget|June 25, 2016
Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activationAngélica Cuapio, Mirte Post, Sabine Cerny-Reiterer, et al.
Oncotarget|October 16, 2013
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survivalAurélie Poli, Jian Wang, Olivia Domingues, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2013
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxiaJoanna Baginska, Elodie Viry, Guy Berchem, et al.
Pageof 9

Showing results (71-80 of 87) with videos related to

Sort By:
Pageof 9
Journal of Translational Medicine|November 7, 2023
Multimeric immunotherapeutic complexes activating natural killer cells towards HIV-1 cureRafaëla Schober, Bianca Brandus, Thessa Laeremans, et al.
Frontiers in Immunology|August 16, 2021
Unbiased Screening Identifies Functional Differences in NK Cells After Early Life Psychosocial StressSara B Fernandes, Neha D Patil, Sophie Meriaux, et al.
Frontiers in Immunology|August 1, 2022
Imprint of Initial Education and Loss of Ly49C/I in Activated Natural Killer Cells of TAP1-KO and C57BL/6 Wildtype MiceNeha D Patil, Olivia Domingues, Cécile Masquelier, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 21, 2014
NK cell killer Ig-like receptor repertoire acquisition and maturation are strongly modulated by HLA class I moleculesMarwan Sleiman, Nicolaas H C Brons, Tony Kaoma, et al.
Immunotargets and Therapy|September 12, 2025
Directed-Complement Activation as a Novel Immunotherapeutic Approach for HER2-Breast CancerCarole Seguin-Devaux, Bianca Brandus, Jean-Marc Plesseria, et al.
Plos One|October 1, 2014
Dynamic contrast enhanced MRI detects early response to adoptive NK cellular immunotherapy targeting the NG2 proteoglycan in a rat model of glioblastomaCecilie Brekke Rygh, Jian Wang, Marte Thuen, et al.
Frontiers in Immunology|July 5, 2017
Human CD56<sup>dim</sup>CD16<sup>dim</sup> Cells As an Individualized Natural Killer Cell SubsetMathieu Amand, Gilles Iserentant, Aurélie Poli, et al.
Oncotarget|June 25, 2016
Maintenance therapy with histamine plus IL-2 induces a striking expansion of two CD56bright NK cell subpopulations in patients with acute myeloid leukemia and supports their activationAngélica Cuapio, Mirte Post, Sabine Cerny-Reiterer, et al.
Oncotarget|October 16, 2013
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survivalAurélie Poli, Jian Wang, Olivia Domingues, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 9, 2013
Granzyme B degradation by autophagy decreases tumor cell susceptibility to natural killer-mediated lysis under hypoxiaJoanna Baginska, Elodie Viry, Guy Berchem, et al.
Pageof 9